Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. American Cancer Society. Cancer Facts & Figures 2021. American Cancer Society; 2021.
2. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26(7):1086-1092. https://doi.org/10.1200/JCO.2007.12.9593
3. Shapiro J, van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090-1098. https://doi.org/10.1016/S1470-2045(15)00040-6
4. Agzarian J, Visscher SL, Knight AW, et al. The cost burden of clinically significant esophageal anastomotic leaks—a steep price to pay. J Thorac Cardiovasc Surg. 2019;157(5):2086-2092. https://doi.org/10.1016/j.jtcvs.2018.10.137
5. Alanezi K, Urschel JD. Mortality secondary to esophageal anastomotic leak. Ann Thorac Cardiovasc Surg. 2004;10(2):5.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献